Bio-Fd&C바이오에프디엔씨

Bio-Fd&C251120· Biotech & PharmaInitiation

Bio-Fd&C: High Margins and Net Cash Balance Sheet, Shares Down 45.1% Over One Year

Bio-Fd&C, a KOSDAQ biotech and pharma company with a market cap of ₩80.0B, closed at ₩9,200 on 2026-10-29, up 28.3% over three months but down 45.1% over one year. Filed statements show operating margins above 30% and very low leverage, and a model estimate sits above the current share price.

Oct 30, 20260 views